每經AI快(kuai)訊，未名醫(yi)藥(yao)8月(yue)1日晚間發布(bu)公(gong)(gong)(gong)告(gao)稱，為(wei)進一(yi)步優(you)化(hua)資(zi)源(yuan)(yuan)配置、提升資(zi)產(chan)(chan)(chan)質(zhi)量、提高運(yun)營效率，山(shan)東未名生(sheng)物(wu)(wu)醫(yi)藥(yao)股(gu)份(fen)有(you)限(xian)公(gong)(gong)(gong)司(si)(si)擬(ni)(ni)在山(shan)東產(chan)(chan)(chan)權(quan)(quan)交(jiao)易中(zhong)心通過公(gong)(gong)(gong)開(kai)掛(gua)牌方式(shi)出售公(gong)(gong)(gong)司(si)(si)全(quan)資(zi)子公(gong)(gong)(gong)司(si)(si)山(shan)東未名天源(yuan)(yuan)生(sheng)物(wu)(wu)科(ke)技有(you)限(xian)公(gong)(gong)(gong)司(si)(si)持有(you)的營口(kou)營新(xin)化(hua)工科(ke)技有(you)限(xian)公(gong)(gong)(gong)司(si)(si)約26.84%股(gu)權(quan)(quan)。本次交(jiao)易以評(ping)估(gu)報告(gao)為(wei)依據，首次公(gong)(gong)(gong)開(kai)掛(gua)牌轉(zhuan)讓價格不低于資(zi)產(chan)(chan)(chan)評(ping)估(gu)機構對(dui)標(biao)的資(zi)產(chan)(chan)(chan)的評(ping)估(gu)價值。由于本次擬(ni)(ni)轉(zhuan)讓參股(gu)公(gong)(gong)(gong)司(si)(si)股(gu)權(quan)(quan)事項擬(ni)(ni)通過公(gong)(gong)(gong)開(kai)掛(gua)牌的方式(shi)進行，最終交(jiao)易價格將根據產(chan)(chan)(chan)權(quan)(quan)交(jiao)易等相關規(gui)則市場化(hua)產(chan)(chan)(chan)生(sheng)和確定。本次交(jiao)易完成后，公(gong)(gong)(gong)司(si)(si)將不再持有(you)營口(kou)化(hua)工股(gu)權(quan)(quan)。

每經頭條(tiao)（nbdtoutiao）——

(記者 蔡鼎)

免(mian)責聲明(ming)：本文內容與數據(ju)(ju)僅供(gong)參考，不(bu)構(gou)成投(tou)資建議，使用前(qian)請核實。據(ju)(ju)此操作，風險(xian)自擔。